Position in WVE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,290
-$260,910 QoQ
Shares Held
9,000
-79.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#186
of 237 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Derivatives in WVE
reported options exposure · as of Jun 30, 2026CallValue
$130,725
CallShares
22,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. WVE ranks #73 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in WVE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,290 | 9,000 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $130,725 | 22,500 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $313,200 | 43,200 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $3,681,550 | 507,800 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $1,160,000 | 160,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $4,834,800 | 284,400 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $326,400 | 19,200 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $1,349,808 | 184,400 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $87,840 | 12,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $222,300 | 34,200 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $351,488 | 43,501 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $202,000 | 25,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $276,336 | 34,200 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $1,546,250 | 125,000 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $483,667 | 39,100 | Shares | Sole | 2025-02-14 | |
| 2021-03-31 | $3,095,598 | 551,800 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $710,226 | 126,600 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $493,438 | 87,957 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $393,500 | 50,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $781,080 | 92,000 | Call | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||